SCHEMBL6969427

SCHEMBL6969427

Nc1cc(CC[O])c2ccccc2n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.53
NCF1 P14598 13/20 0.47
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
GLA P06280 2/20 0.44
HPGD P15428 2/20 0.44
CASP1 P29466 2/20 0.44
CASP7 P55210 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HSD17B10 Q99714 2/20 0.44
CHRM2 P08172 1/20 0.44
ADRA2A P08913 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CHRM1 P11229 1/20 0.44
NQO2 P16083 1/20 0.44
MAOA P21397 1/20 0.44
DRD1 P21728 1/20 0.44
ACHE P22303 1/20 0.44
SLC6A2 P23975 1/20 0.44
ADRA1A P35348 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6968709 0.85 BACE1 (0.56) BACE1NCF1KDM4EALDH1A1GLA
SCHEMBL6665713 0.82 BACE1 (0.53) BACE1NCF1KDM4EALDH1A1GLA
SCHEMBL7050208 0.81 BACE1 (0.61) BACE1NCF1KDM4EALDH1A1GLA
SCHEMBL2330449 0.81 PARP1 (0.50) BACE1NCF1KDM4ECHRM1TSHR
SCHEMBL832149 0.79 BACE1 (0.58) BACE1NCF1KDM4EALDH1A1GLA
SCHEMBL16836343 0.79 TLR8 (0.58) BACE1NCF1KDM4EALDH1A1GLA
SCHEMBL6983097 0.79 KDM4E (0.46) KDM4EALDH1A1HPGDMAOAPOLB
SCHEMBL7262454 0.79 KDM4E (0.40) KDM4EALDH1A1GLAHPGDSMN1; SMN2
SCHEMBL6964689 0.79 CYP1A2 (0.56) NCF1KDM4EALDH1A1SMN1; SMN2RAB9A
SCHEMBL10630961 0.78 TLR8 (0.59) BACE1NCF1KDM4EALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6642255-B2 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-11-04 US disclosed
EP-1355648-A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) Bristol-Myers Squibb Pharma Company (US) 2003-10-29 EP disclosed
WO-2002055491-A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) BRISTOL MYERS SQUIBB COMPANY P (US) 2002-07-18 WO disclosed